Aug 11, 2026 · 7 min
Asian markets rally on obesity drugs, AI demand and Singapore growth
Chinese Pharma Rallies, Singapore Stocks Rise, Samsung Climbs
The episode connects distinct market gains across Asia to healthcare commercialization, economic forecasts, semiconductor demand and longer-term urban investment.
- 1Chinese healthcare shares advanced as Gan & Lee secured European commercialization rights for its obesity drug.
- 2Singapore stocks rose after a higher 2026 growth forecast highlighted wealth management, data centers and AI.
- 3Samsung and other South Korean technology shares gained on exports, shareholder returns and high-bandwidth memory demand.
Don't miss
The episode shifts from daily Asian stock catalysts to the longer investment horizon of AI-enabled smart cities, using Dubai to show how planning meets population growth.
The brief
Chinese healthcare stocks rallied after Gan & Lee Pharmaceuticals secured European commercialization rights for its obesity drug, adding momentum to a sector already watched for oncology strength.
Singapore shares gained after the government raised the upper end of its 2026 growth forecast, with wealth management, data centers and AI supporting the outlook.
South Korean technology stocks climbed on strong exports, expected shareholder returns and optimism about AI-driven high-bandwidth memory demand, with Samsung’s position versus Hynix in focus.
The market discussion broadens into smart-city development, where AI could accelerate urban systems and Dubai illustrates how long-term planning can respond to rapid population growth.
The episode’s central thread is that markets are pricing both immediate catalysts, such as drug rights and exports, and durable bets on AI infrastructure and urban growth.
What was said on this episode
19 statements · 18 positive · 1 negative
Indian healthcare has risen approximately 20% this year.
“Indian healthcare, for example, up 20% odd in the year.”
Listen at 0:51
- Desmond Stephenson Chinese pharmaceutical companies licensing anti-obesity drugs to EuropePositive1:01
Chinese pharmaceutical companies have progressed in licensing anti-obesity drugs to Europe.
“They've made some progress licensing anti-obesity drugs to Europe.”
Listen at 1:01
Farmeron shares have risen 3%.
“Farmeron, for example, is up 3%.”
Listen at 1:19
Hanso Pharma shares have risen 3%.
“Hanso Pharma, up 3%.”
Listen at 1:22
Celtrion shares have risen 5%.
“Celtrion. which is up 5%”
Listen at 1:30
Asian pharma is emerging as an outperforming defensive trade amid AI volatility.
“pharma emerging here in the second half of the year as a real outperformer and a place to hide from some of this AI volatility”
Listen at 1:36
Singapore’s wealth-management and AI-hub roles are driving its growth outlook.
“this is being powered by both its status as a wealth management hub and an AI hub.”
Listen at 2:12
The SDI index has a Sharpe ratio above four.
“the SDI index has a Sharpe of over four”
Listen at 2:25
Yang Zhejiang shipping shares have risen nearly 10%.
“Yang Zhejiang shipping is up almost 10%.”
Listen at 2:35
OCBC shares remain above record highs and are up 3% today.
“OCBC carries on past its record highs. It's up 3% again today.”
Listen at 2:46
Samsung’s high-end phone business is performing reasonably well.
“Their high-end phone business is doing reasonably well.”
Listen at 3:23
Samsung’s standard DRAM business is performing strongly.
“Their vanilla DRAM business is doing really well”
Listen at 3:26
Samsung shares are up 3.6%, versus Hynix up 1%.
“Samsung is up 3.6% versus Hynix up just 1%.”
Listen at 3:40
Samsung’s stronger performance may stabilize sentiment in South Korea.
“it might actually stabilize sentiment there.”
Listen at 3:47
Zhongji Inolite and eOptolink shares are up around 4%.
“Zhongji Inolite and eOptolink up around 4% in China and in Hong Kong.”
Listen at 4:18
U.S. optical companies fell between 8% and 9%.
“the U.S. players were down anywhere from 8% to 9% last night.”
Listen at 4:24
AI will compress processes in smart-city systems.
“AI will allow in the smart city space to compress a lot of things.”
Listen at 5:15
Dubai responded effectively to its sudden population increase.
“they reacted very well to it.”
Listen at 5:41
Dubai has a long-term urban-planning vision.
“They have a long-term urban planning vision”
Listen at 5:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Bloomberg Audio Studios
AsiaBooks & mentions
Listen to the full episode and explore every guest, topic, and moment on PodLume.